
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18302040
[patent_doc_number] => 11623931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-11
[patent_title] => Bicyclic compounds for diagnosis and therapy
[patent_app_type] => utility
[patent_app_number] => 16/894682
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35769
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 424
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894682
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894682 | Bicyclic compounds for diagnosis and therapy | Jun 4, 2020 | Issued |
Array
(
[id] => 17377085
[patent_doc_number] => 11235074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Contrast agents for magnetic resonance imaging
[patent_app_type] => utility
[patent_app_number] => 16/946056
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 6739
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946056
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946056 | Contrast agents for magnetic resonance imaging | Jun 3, 2020 | Issued |
Array
(
[id] => 16400235
[patent_doc_number] => 20200341093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => METHOD FOR PREPARATION OF HIGHLY POLARIZED NUCLEAR SPINS CONTAINING SAMPLES AND USES THEREOF FOR NMR AND MRI
[patent_app_type] => utility
[patent_app_number] => 16/891437
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16891437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/891437 | Method for preparation of highly polarized nuclear spins containing samples and uses thereof for NMR and MRI | Jun 2, 2020 | Issued |
Array
(
[id] => 16481911
[patent_doc_number] => 20200375511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => TAILORED DRUG DELIVERY VEHICLES FOR IN VIVO PROTECTION OF ANALYTE SENSING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/887704
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887704
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887704 | TAILORED DRUG DELIVERY VEHICLES FOR IN VIVO PROTECTION OF ANALYTE SENSING COMPOUNDS | May 28, 2020 | Pending |
Array
(
[id] => 17323544
[patent_doc_number] => 11214538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Farnesoid X receptor agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/872985
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40548
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 598
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16872985
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/872985 | Farnesoid X receptor agonists and uses thereof | May 11, 2020 | Issued |
Array
(
[id] => 18186427
[patent_doc_number] => 11576986
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Macrocyclic chelators and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/869771
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 42197
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869771
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869771 | Macrocyclic chelators and methods of use thereof | May 7, 2020 | Issued |
Array
(
[id] => 16359480
[patent_doc_number] => 20200316231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Compositions And Methods For Imaging Immune Cells
[patent_app_type] => utility
[patent_app_number] => 16/870484
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870484 | Compositions And Methods For Imaging Immune Cells | May 7, 2020 | Pending |
Array
(
[id] => 16252233
[patent_doc_number] => 20200261607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => DOTMP KIT FORMULATIONS FOR RADIOISOTOPES
[patent_app_type] => utility
[patent_app_number] => 16/866001
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7415
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866001
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/866001 | DOTMP kit formulations for radioisotopes | May 3, 2020 | Issued |
Array
(
[id] => 16236886
[patent_doc_number] => 20200254120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => ORGAN PROTECTION IN PSMA-TARGETED RADIONUCLIDE THERAPY OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/860925
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860925
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860925 | Organ protection in PSMA-targeted radionuclide therapy of prostate cancer | Apr 27, 2020 | Issued |
Array
(
[id] => 16236885
[patent_doc_number] => 20200254119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/858329
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858329
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858329 | Imaging agents | Apr 23, 2020 | Issued |
Array
(
[id] => 17235619
[patent_doc_number] => 11179482
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Chemiluminescent probes for diagnostics and in vivo imaging
[patent_app_type] => utility
[patent_app_number] => 16/850333
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 22
[patent_no_of_words] => 24913
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850333 | Chemiluminescent probes for diagnostics and in vivo imaging | Apr 15, 2020 | Issued |
Array
(
[id] => 19314277
[patent_doc_number] => 12040102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => Technetium-99M generator for enriched molybdenum
[patent_app_type] => utility
[patent_app_number] => 16/850783
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4689
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850783
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850783 | Technetium-99M generator for enriched molybdenum | Apr 15, 2020 | Issued |
Array
(
[id] => 16359465
[patent_doc_number] => 20200316216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/814714
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814714 | COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY | Mar 9, 2020 | Abandoned |
Array
(
[id] => 18153070
[patent_doc_number] => 11566031
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/873245
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9290
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16873245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/873245 | Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof | Mar 3, 2020 | Issued |
Array
(
[id] => 17410069
[patent_doc_number] => 11250965
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-02-15
[patent_title] => Systems and methods for preparing tailored radioactive isotope solutions
[patent_app_type] => utility
[patent_app_number] => 16/803525
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 7314
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16803525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/803525 | Systems and methods for preparing tailored radioactive isotope solutions | Feb 26, 2020 | Issued |
Array
(
[id] => 16108691
[patent_doc_number] => 20200206368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => BIOLOGICS LABELING SYSTEM AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/732193
[patent_app_country] => US
[patent_app_date] => 2019-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/732193 | BIOLOGICS LABELING SYSTEM AND METHODS THEREOF | Dec 30, 2019 | Abandoned |
Array
(
[id] => 17267492
[patent_doc_number] => 11192903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography
[patent_app_type] => utility
[patent_app_number] => 16/723601
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 38
[patent_no_of_words] => 10521
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723601
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/723601 | Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography | Dec 19, 2019 | Issued |
Array
(
[id] => 17168666
[patent_doc_number] => 20210322336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => METHOD FOR PREPARING ALBUMIN NANOPARTICLES BASED ON FREE RADICAL OXIDATION
[patent_app_type] => utility
[patent_app_number] => 17/292455
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292455 | Method for preparing albumin nanoparticles based on free radical oxidation | Dec 15, 2019 | Issued |
Array
(
[id] => 16108693
[patent_doc_number] => 20200206369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => IMAGING OF TUMOR-ASSOCIATED MACROPHAGES
[patent_app_type] => utility
[patent_app_number] => 16/705188
[patent_app_country] => US
[patent_app_date] => 2019-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16705188
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/705188 | IMAGING OF TUMOR-ASSOCIATED MACROPHAGES | Dec 4, 2019 | Abandoned |
Array
(
[id] => 16760419
[patent_doc_number] => 20210106000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => ANTI-FREEZING COMPOSITION COMPRISING GOLD NANOPARTICLE WITH PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/702059
[patent_app_country] => US
[patent_app_date] => 2019-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16702059
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/702059 | Anti-freezing composition comprising gold nanoparticle with peptide | Dec 2, 2019 | Issued |